COVID-19 vaccines are now being distributed across the USA and administered to an expanding universe of patient populations. It’s clear that retail pharmacies will play a critical role in the vaccination of the general public in the coming months.
Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.
Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. While a study from two decades ago may no longer seem relevant, the fact is, the vast majority of today’s IVs are still being prepared through error-prone manual processes.
I invite you to join us during ASHP Midyear 2020 to learn how the Autonomous Pharmacy is transforming inefficient, error-prone, manual processes to help pharmacies enhance safety, improve efficiency, and drive business outcomes.
Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines. Exacerbating the problem are challenges with outsourced compounding facilities, including supply chain disruption and lack of quality.
Medication management, especially with specialized drugs, has become increasingly complex for clinicians. Complicating matters is that 80% of medication management is done outside of the pharmacy.
With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., the opioid crisis is one of the major challenges healthcare is facing, specifically for pharmacies currently managing medication diversion. And this crisis is only exacerbated by COVID-19.
Omnicell’s Winter 2020 release includes new advancements in automation, intelligence, and technology-enabled services to streamline workflows and expand inventory management capabilities to drive improved outcomes and operational success. Read more about the Company’s product roadmap and strategic vision.
Today, I was excited to join thousands of registrants representing pharmacy, nursing, informatics, and healthcare leaders for the launch of Omnicell Illuminate 2020 , one of the year’s biggest digital events dedicated to technology-driven medication management.
Let’s face it: medication management is challenging. Today 33% of a nurse’s time is spent interacting with technology with only 16% spent at the bedside. By increasing medication management efficiencies we can increase time at the bedside. And that’s good news for hospitals and patients alike.
Studies show that 1 in 10 healthcare workers will experience substance abuse at some point during their lives. Yet despite being the hardest hit by diversion, many health systems lack the necessary tools to detect these incidences in real-time.
For Massachusetts General Hospital – the No. 6-ranked hospital in the country by US News & World Report – finding and retrieving medication from the basement and delivering to distant patient floors can cause lengthy medication administration delays that can be dangerous to patients with urgent care needs.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.